Relevate Health Acquires Level Ex Games' Pharma & Life Sciences Division from Brainlab

September 9, 2024

Relevate Health Group, LLC has purchased the pharma and life sciences division of Level Ex Games from Munich-based Brainlab. The deal — supported by a senior credit facility arranged by Monroe Capital — will rebrand the unit as Level Ex Games Powered by Relevate Health and expand Relevate's game-based learning and omnichannel HCP engagement capabilities for pharmaceutical and life science clients.

Buyers
Relevate Health Group, LLC
Targets
Level Ex Games (pharma and life sciences division)
Sellers
Brainlab
Platforms
Relevate Health Group, LLC
Location
Illinois, United States
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.